statistiche ricercatore

Continente	#
NA - Nord America	955
EU - Europa	466
AS - Asia	463
SA - Sud America	73
Continente sconosciuto - Info sul continente non disponibili	26
AF - Africa	17
OC - Oceania	3
Totale	2.003

Nazione	#
US - Stati Uniti d'America	925
IT - Italia	147
SG - Singapore	147
CN - Cina	83
DE - Germania	69
VN - Vietnam	63
HK - Hong Kong	57
BR - Brasile	51
SE - Svezia	49
GB - Regno Unito	42
BD - Bangladesh	38
FI - Finlandia	29
FR - Francia	23
RU - Federazione Russa	23
CA - Canada	17
ES - Italia	16
ID - Indonesia	11
IN - India	10
LT - Lituania	10
NL - Olanda	10
BG - Bulgaria	9
PL - Polonia	9
MX - Messico	8
AR - Argentina	7
TR - Turchia	7
KR - Corea	6
IR - Iran	5
JP - Giappone	5
SI - Slovenia	5
AE - Emirati Arabi Uniti	4
BE - Belgio	4
CL - Cile	4
MY - Malesia	4
ZA - Sudafrica	4
AU - Australia	3
CH - Svizzera	3
CO - Colombia	3
CZ - Repubblica Ceca	3
PE - Perù	3
PK - Pakistan	3
SA - Arabia Saudita	3
SD - Sudan	3
VE - Venezuela	3
AL - Albania	2
AT - Austria	2
BY - Bielorussia	2
DO - Repubblica Dominicana	2
IE - Irlanda	2
IQ - Iraq	2
KZ - Kazakistan	2
MA - Marocco	2
MN - Mongolia	2
PS - Palestinian Territory	2
SN - Senegal	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
DK - Danimarca	1
DZ - Algeria	1
EC - Ecuador	1
EG - Egitto	1
ET - Etiopia	1
EU - Europa	1
GA - Gabon	1
GE - Georgia	1
GH - Ghana	1
GR - Grecia	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LK - Sri Lanka	1
LV - Lettonia	1
PA - Panama	1
PH - Filippine	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TH - Thailandia	1
UA - Ucraina	1
VC - Saint Vincent e Grenadine	1
Totale	1.979

Nome	#
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study.	370
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia	321
Circulating Mitochondrial DNA and Lipopolysaccharide-Binding Protein but Not Bacterial DNA Are Increased in Acute Human Immunodeficiency Virus Infection.	313
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study	294
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period	269
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)	225
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study	211
Totale	2.003

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	274	16	8	27	15	15	8	41	18	21	18	46	41
2022/2023	243	33	39	18	24	29	26	6	23	28	1	1	15
2023/2024	171	2	7	12	13	27	26	4	17	13	14	14	22
2024/2025	415	18	8	5	26	62	72	38	26	52	31	28	49
2025/2026	728	51	22	52	82	111	35	92	43	87	52	48	53
2026/2027	24	24	0	0	0	0	0	0	0	0	0	0	0
Totale													2.003